Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MAPK-driven glioma progression and reprogramming of the tumor-associated immune response.

Neuro-oncology·2026
Same author

Single-nucleus profiling of postmortem diffuse midline gliomas identifies mitochondrial biogenesis as a resistance mechanism to imipridone therapy.

Neuro-oncology·2026
Same author

Chromosome 3p Deletion Leads to Extensive Genomic Alterations in Diverse Cancers and Confers Synthetic Lethality in Uveal Melanoma.

Cancers·2026
Same author

Chromosome 3p deletion leads to extensive genomic alterations in diverse cancers and confers synthetic lethality in uveal melanoma.

bioRxiv : the preprint server for biology·2026
Same author

UV induces common cutaneous amyloid-like melanosomal protein aggregates.

bioRxiv : the preprint server for biology·2025
Same author

Developmental Plasticity and Stromal Co-option Shape a Pituitary Neuroendocrine Tumor Transcriptional Continuum.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: May 17, 2026

Introductory Analysis and Validation of CUT&RUN Sequencing Data
04:58

Introductory Analysis and Validation of CUT&RUN Sequencing Data

Published on: December 13, 2024

CHANCE: comprehensive software for quality control and validation of ChIP-seq data.

Aaron Diaz, Abhinav Nellore, Jun S Song

    Genome Biology
    |October 17, 2012
    PubMed
    Summary

    CHANCE software enhances ChIP-seq experiments by providing quality control and protocol optimization. This tool estimates immunoprecipitation quality, identifies biases, and normalizes data for reliable results.

    More Related Videos

    Genome-wide Snapshot of Chromatin Regulators and States in Xenopus Embryos by ChIP-Seq
    10:23

    Genome-wide Snapshot of Chromatin Regulators and States in Xenopus Embryos by ChIP-Seq

    Published on: February 26, 2015

    Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
    11:52

    Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

    Published on: August 4, 2016

    Related Experiment Videos

    Last Updated: May 17, 2026

    Introductory Analysis and Validation of CUT&RUN Sequencing Data
    04:58

    Introductory Analysis and Validation of CUT&RUN Sequencing Data

    Published on: December 13, 2024

    Genome-wide Snapshot of Chromatin Regulators and States in Xenopus Embryos by ChIP-Seq
    10:23

    Genome-wide Snapshot of Chromatin Regulators and States in Xenopus Embryos by ChIP-Seq

    Published on: February 26, 2015

    Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
    11:52

    Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

    Published on: August 4, 2016

    Area of Science:

    • Genomics
    • Molecular Biology
    • Bioinformatics

    Background:

    • Chromatin immunoprecipitation sequencing (ChIP-seq) is crucial for mapping protein-DNA interactions and epigenetic marks genome-wide.
    • Effective quality control and protocol optimization are essential for reliable ChIP-seq data.

    Purpose of the Study:

    • To introduce CHANCE (ChIP-seq ANalytics and Confidence Estimation), a standalone software package for comprehensive ChIP-seq analysis.
    • To provide researchers with a user-friendly tool for assessing ChIP-seq data quality and refining experimental protocols.

    Main Methods:

    • CHANCE is a standalone, graphical software package.
    • It estimates immunoprecipitation strength and quality.
    • The software identifies biases, performs multi-sample normalization, and compares data against ENCODE datasets and qPCR-validated regions.

    Main Results:

    • CHANCE offers rapid estimation of ChIP-seq experiment quality.
    • It facilitates identification of experimental biases and data inconsistencies.
    • The software generates informative graphical reports for clear data interpretation.

    Conclusions:

    • CHANCE provides a robust solution for ChIP-seq quality control and protocol optimization.
    • Its user-friendly interface and comprehensive features aid researchers in obtaining high-confidence ChIP-seq results.
    • The tool supports data comparison and normalization, enhancing the reliability of epigenetic and protein-DNA interaction studies.